Showing results (61-70 of 114) with videos related to

Sort By:
Pageof 12
Acta Neuropsychiatrica|January 10, 2018
BDNF and NRG1 polymorphisms and temperament in selective serotonin reuptake inhibitor-treated patients with major depressionKadri Andre, Olli Kampman, Merja Viikki, et al.
Acta Neuropsychiatrica|April 18, 2024
Polymorphisms in ERBB4 and TACR1 associated with dry mouth in clozapine-treated patientsHanna Puolakka, Anssi Solismaa, Leo-Pekka Lyytikäinen, et al.
The Journal of ECT|March 12, 2013
Effects of S-ketamine as an anesthetic adjuvant to propofol on treatment response to electroconvulsive therapy in treatment-resistant depression: a randomized pilot studyKaija Järventausta, Wojciech Chrapek, Olli Kampman, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 13, 2017
Histaminergic gene polymorphisms associated with sedation in clozapine-treated patientsAnssi Solismaa, Olli Kampman, Leo-Pekka Lyytikäinen, et al.
Neuroreport|November 13, 2004
Neuregulin genotype and medication response in Finnish patients with schizophreniaOlli Kampman, Sami Anttila, Ari Illi, et al.
Psychiatric Genetics|June 5, 2003
NOTCH4 gene promoter polymorphism is associated with the age of onset in schizophreniaSami Anttila, Olli Kampman, Ari Illi, et al.
Acta Neuropsychiatrica|September 4, 2023
Genetic risk scores associated with temperament clusters in Finnish depression patientsSimo-Pekko Salminen, Anssi Solismaa, Leo-Pekka Lyytikäinen, et al.
Brain and Behavior|April 20, 2018
Low tumor necrosis factor-α levels predict symptom reduction during electroconvulsive therapy in major depressive disorderAnnamari Sorri, Kaija Järventausta, Olli Kampman, et al.
Brain and Behavior|October 2, 2018
Effect of electroconvulsive therapy on brain-derived neurotrophic factor levels in patients with major depressive disorderAnnamari Sorri, Kaija Järventausta, Olli Kampman, et al.
Preventive Medicine|March 3, 2012
Lifetime leisure-time physical activity and the risk of depressive symptoms at the ages of 65-74 years: the FIN-D2D surveyKatariina Korniloff, Mauno Vanhala, Hannu Kautiainen, et al.
Pageof 12